10X GENOMICS INC
10X GENOMICS INC
Aktie · US88025U1097 · TXG · A2PPQJ (XNAS)
Übersicht
Kein Kurs
16.09.2025 23:50
1 Tag
-
1 Woche
-
1 Monat
-
3 Monate
-
6 Monate
-
Jahr bis heute
-
1 Jahr
-
2 Jahre
-
3 Jahre
-
4 Jahre
-
5 Jahre
-
10 Jahre
-
20 Jahre
-
Max
-
Analyst Grade Summary
gauge-img
Kaufen
Starker Kauf
Kaufen
Halten
Verkaufen
Starker Verkauf
0
12
8
1
0
Aktuelle Kurse von 10X GENOMICS INC
BörseTickerWährungLetzter UmsatzKursTagesveränderung
XNAS: NASDAQ
NASDAQ
TXG
USD
16.09.2025 23:50
13,34 USD
-0,010 USD
-0,07 %
Free Float & Liquidität
Free Float 88,70 %
Shares Float 110,42 M
Ausstehende Aktien 124,48 M
Investierte Fonds

Folgende Fonds haben in 10X GENOMICS INC investiert:

Fonds
iShares Edge MSCI USA Momentum Factor UCITS ETF USD (Dist)
Vol. in Mio
26,43
Anteil (%)
0,20 %
Fonds
iShares MSCI World Health Care Sector UCITS ETF USD (Dist)
Vol. in Mio
632,22
Anteil (%)
0,17 %
Fonds
iShares Edge MSCI World Minimum Volatility UCITS ETF EUR Hedged (Acc)
Vol. in Mio
61,33
Anteil (%)
0,06 %
Fonds
iShares Edge MSCI World Minimum Volatility UCITS ETF USD (Dist)
Vol. in Mio
1,60
Anteil (%)
0,06 %
Fonds
iShares MSCI USA Momentum Factor ESG UCITS ETF USD (Acc)
Vol. in Mio
929,27
Anteil (%)
0,06 %
Firmenprofil zu 10X GENOMICS INC Aktie
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumables products. Its single cell solutions runs on its chromium instruments, which include single cell gene expression for measuring gene activity on a cell-by-cell basis; single cell immune profiling for measuring the activity of immune cells and their targets; single cell Assay for Transposase Accessible Chromati (ATAC) for measuring epigenetics comprising the physical organization of DNA; and single cell multiome ATAC + gene expression for measuring the genetic activity and epigenetic programming in the same cells across tens of thousands of cells in a single experiment. The company also provides visium spatial gene expression solution for measuring spatial gene expression patterns across a single tissue sample or gene expression and protein co-detection when combined with immunofluorescence. It serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.

Unternehmensdaten

Name 10X GENOMICS INC
Firma 10x Genomics, Inc.
Symbol TXG
Website https://www.10xgenomics.com
Heimatbörse XNAS NASDAQ
WKN A2PPQJ
ISIN US88025U1097
Wertpapierart Aktie
Sektor Healthcare
Branche Medical - Healthcare Information Services
CEO Serge Saxonov
Marktkapitalisierung 2 Mrd.
Land Vereinigte Staaten von Amerika
Währung USD
Mitarbeiter 1,3 T
Adresse 6230 Stoneridge Mall Road, 94588-3260 Pleasanton
IPO Datum 2019-09-12

Aktien-Splits

Datum Split
17.07.2006 1:2

Ticker Symbole

Name Symbol
Frankfurt 1KJ.F
NASDAQ TXG
Weitere Aktien
Investoren, die 10X GENOMICS INC halten, haben auch folgende Aktien im Depot:
DWS TUERKEI
DWS TUERKEI Fonds
TCFC Finance Limited
TCFC Finance Limited Aktie
Die Finanzplattform MoneyPeak trackt und analysiert Investitionen und Portfolios. Vom Wertpapier-Depot bis zum Crypto-Kauf.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.
Impressum Datenschutz Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025